- Combo self-testing has sensitivity of more than 98%
- Differentiates between COVID and Flu A/B accurately within 15 minutes
- Access to new kits now available at selected pharmacies nationally.
28 November 2022, SYDNEY: There is a new weapon to help combat the current COVID-19 wave, with Australians are now able to purchase Touch Biotechnology’s Combo Rapid Antigen test for COVID-19 and Influenza A and B at pharmacies nationally.
Touch Biotechnology’s new SARS-CoV-2 & Flu A/B Antigen Combo Test (Self-Testing) Kit has a sensitivity of more than 98% (very high sensitivity). It was one of the first Therapeutic Goods Administration (TGA) approved multi-virus rapid antigen tests in the Australian market, with approval obtained in September 2022.
General Manager of Sydney-based Touch Biotechnology (TouchBio), Mazz Gencer, said “Australians want to enjoy their freedoms over the summer months and spend long overdue time up with friends and family.”
“It is timely with increased COVID cases across Australia and off the back of the worst flu season in five years that people can now purchase the new Combo Test (Self-Testing) Kit from selected pharmacies” Mr Gencer said.
The symptoms of COVID and Flu A/B are very similar, the TouchBio combined Rapid Antigen self-test kit enables people to test for all three at the same time with a very high level of accuracy. This helps them to identify their symptoms within 15 minutes, get a consultation from a health professional for the right treatment, and make timely decisions about their interactions in the community from the comfort of their own homes.
People are recommended to take a TouchBio SARS-CoV-2 & Flu A/B Antigen Combo Test (Self-Testing) Kit when they feel unwell, have any symptoms, or have been in contact with someone who has COVID-19, or Influenza A or B viruses.
In collaboration with national wholesalers and distributors such as Symbion, TouchBio Combo Kits can now be purchased from selected stores of TerryWhite Chemmart, Good Price Pharmacy Warehouse, and more.
The TouchBio SARS-CoV-2 & Flu A/B Antigen Combo Test (Self-Testing) Kit carries the unique official TGA number of ARTG 395591, and has Very High Sensitivity for the Flu & Covid.
About Touch Biotechnology: Founded in 2020 in Sydney Australia, Touch Biotechnology is one of the leading manufacturers and developers of advanced antimicrobial protection solutions and rapid in-vitro antigen tests. It is dedicated to developing solutions that are evidently effective, and continually demonstrates a commitment to building products that have a positive impact on human lives, while remaining socially and environmentally responsible.
Media Contact Information:
Marketing and Product Administrator
+61 1300 166 282